Literature DB >> 3537152

Inhibition of complement by culture supernatants of Aspergillus fumigatus.

R G Washburn, C H Hammer, J E Bennett.   

Abstract

Aspergillus fumigatus produced a water-soluble extracellular material that inhibited the opsonization of fungal cells by normal human serum. Blastospores of Cryptococcus neoformans and conidia from A. fumigatus or Aspergillus niger were used as fungal targets for ingestion by human monocytes. The opsonic inhibitor from A. fumigatus was found to decrease binding of complement component C3b to fungal surfaces by selectively interfering with activation of the alternative complement pathway. Inhibition of complement did not appear to result simply from proteolysis, as judged by the minimal degradation of casein and of purified C3 and C4. The complement-inhibiting activity was partially labile to heating at 100 C and could be concentrated by using dialysis tubing with a 10,000-dalton exclusion limit. Aspergillus flavus, which is also a pathogen for humans, also produced this activity; A. niger did not. We speculate that this material may represent a pathogenesis factor for Aspergillus species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537152     DOI: 10.1093/infdis/154.6.944

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Culture filtrates of Aspergillus fumigatus induce different modes of cell death in human cancer cell lines.

Authors:  P Daly; S Verhaegen; M Clynes; K Kavanagh
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins.

Authors:  Rajashri Shende; Sarah Sze Wah Wong; Srikanth Rapole; Rémi Beau; Oumaima Ibrahim-Granet; Michel Monod; Karl-Heinz Gührs; Jayanta Kumar Pal; Jean-Paul Latgé; Taruna Madan; Vishukumar Aimanianda; Arvind Sahu
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

3.  Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography.

Authors:  R G Washburn; D J DeHart; D E Agwu; B J Bryant-Varela; N C Julian
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

Review 4.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 5.  Complement resistance in microbes.

Authors:  M C Moffitt; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1994

Review 6.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 7.  Immunological aspects of fungal pathogenesis.

Authors:  G S Deepe; W E Bullock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

8.  Interactions between conidia of Aspergillus fumigatus and human complement component C3.

Authors:  J E Sturtevant; J P Latgé
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

9.  The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence.

Authors:  H F Tsai; Y C Chang; R G Washburn; M H Wheeler; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

10.  Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein.

Authors:  G Vogl; I Lesiak; D B Jensen; S Perkhofer; R Eck; C Speth; C Lass-Flörl; P F Zipfel; A M Blom; M P Dierich; R Würzner
Journal:  Mol Immunol       Date:  2007-10-25       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.